Pharmaceutical

The Neuroscience of Inclusion and Diversity: Unlocking High-Impact Team Performance

NORTHAMPTON, MA / ACCESSWIRE / October 29, 2024 / Diversity and inclusion are not only core elements of Teva's cultural…

2 months ago

Synoligo Biotechnologies Unveils New Facility to Enhance Oligonucleotide Synthesis Capacity

MORRISVILLE, N.C., Oct. 29, 2024 /PRNewswire/ -- Synoligo Biotechnologies Inc., a Contract Research and Development Organization (CRDO) based in Research…

2 months ago

DELFI Diagnostics Names Robert Guigley as Chief Commercial Officer to Expand Access to Early Cancer Screening

Industry Leader to Drive Adoption of Breakthrough Blood-Based Technology and Fragmentomics Platform for Improved Screening and Monitoring BALTIMORE and PALO…

2 months ago

QuantalX Introduces a Breakthrough in the Diagnosis and Classification of Parkinson’s Disease

NEW YORK, Oct. 29, 2024 /PRNewswire/ -- QuantalX Neuroscience, a leader in objective neurodiagnostic technology, announces a significant discovery in the…

2 months ago

CAS introduces stereoselective labeling in the CAS SciFinder® retrosynthesis tool – a first-of-its-kind capability in the world of scientific technology solutions

The new capability combines the industry-leading CAS Content Collection™ with cutting-edge technology and enables scientists to innovate with confidence COLUMBUS, Ohio,…

2 months ago

Top 10 Pharma Selects TrueMed for Advanced Counterfeit Drug Investigations

HELSINKI, Oct. 29, 2024 /PRNewswire/ -- TrueMed, a leading provider of anti-counterfeiting technology solutions, is proud to announce its new partnership…

2 months ago

AION Labs Launches New AI Startup to Accelerate Identification of Active Small Molecules for Drug Discovery

ProPhet, Newest Startup Launched by Israel-Based Venture Studio, Aims to Reduce Time and Cost of Finding Molecules for New Drug…

2 months ago

Laxxon Medical Names Lauren Chung PhD MBA as Chief Financial Officer

NEW YORK, NY / ACCESSWIRE / October 29, 2024 / Laxxon Medical Corp., a leading pharma technology platform company focusing…

2 months ago

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024

SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q)…

2 months ago